Cutler Group’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10
Closed -$834 3010
2023
Q4
$0 Buy
+10
New +$1.95K ﹤0.01% 4005
2023
Q3
Sell
-120
Closed -$19.5K 4083
2023
Q2
$17K Sell
120
-170
-59% -$25.4K ﹤0.01% 1940
2023
Q1
$59K Buy
+290
New +$49.3K 0.01% 1245
2022
Q4
Sell
-136
Closed -$27.9K 4853
2022
Q3
$32K Buy
+136
New +$31.6K ﹤0.01% 2242
2022
Q2
Sell
-20
Closed -$10K 5350
2022
Q1
$7K Sell
20
-334
-94% -$131K ﹤0.01% 3890
2021
Q4
$91K Buy
354
+214
+153% +$49.2K ﹤0.01% 1919
2021
Q3
$29K Sell
140
-1,959
-93% -$417K ﹤0.01% 3001
2021
Q2
$405K Buy
+2,099
New +$471K 0.02% 867
2020
Q4
Sell
-10
Closed -$3.81K 5181
2020
Q3
$5K Sell
10
-5
-33% -$3.23K ﹤0.01% 3504
2020
Q2
$10K Buy
+15
New +$18.8K ﹤0.01% 2870
2020
Q1
Sell
-1
Closed -$2.85K 4377
2019
Q4
$2K Sell
1
-3
-75% -$10.7K ﹤0.01% 3463
2019
Q3
$17K Buy
+4
New +$16.5K ﹤0.01% 2296
2018
Q4
Sell
-1
Closed -$7.34K 4294
2018
Q3
$4K Sell
1
-1
-50% -$4.83K ﹤0.01% 3185
2018
Q2
$7K Hold
2
﹤0.01% 2903
2018
Q1
$12K Buy
2
+1
+100% +$6.95K ﹤0.01% 2657
2017
Q4
$12K Sell
1
-1
-50% -$9.96K ﹤0.01% 2987
2017
Q3
$15K Hold
2
﹤0.01% 3417
2017
Q2
$23K Hold
2
﹤0.01% 3274
2017
Q1
$42K Hold
2
﹤0.01% 2583
2016
Q4
$62K Hold
2
﹤0.01% 2334
2016
Q3
$51K Buy
2
+1
+100% +$46.8K ﹤0.01% 2444
2016
Q2
$95K Sell
1
-2
-67% -$161K ﹤0.01% 1732
2016
Q1
$303K Buy
+3
New +$384K 0.02% 762

Other funds holding LABD

Cutler Group's LABD Position: Q1 2024 in Review

Cutler Group sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q1 2024, closing a stake of 10 shares — an estimated $834 sold.

Cutler Group first reported a position in LABD in Q1 2016 and held it in 23 quarters. The position peaked at $405K in Q2 2021. 21 funds tracked by Wall St. Rank hold LABD as of Q1 2024.

  • Cutler Group reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 10 Direxion Daily S&P Biotech Bear 3X ETF shares in Q1 2024, an estimated $834.
  • Cutler Group first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q1 2016 and held it in 23 quarters.
  • Cutler Group's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $405K in Q2 2021.
  • 21 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.